PRESS RELEASES

Stemedica Establishes Stem Cell Commercial Manufacturing Facility

Stemedica expands manufacturing capacity for Phase III and commercial stem cell products San Diego, California and Epalinges, Switzerland – November 10, 2015 – Stemedica Cell Technologies, Inc., a leading manufacturer of adult, allogeneic stem cells and preserved stem...

Stemedica Awarded US Patent for Transgenic Therapeutic Stem Cells

Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic stem cells and stem cell factors, received United States Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for Their Use and Manufacture.” The patent issued on July...

Stemedica Issued US Patent Method for Identifying Neuripotent Cells

Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced today that the Company has been issued Patent No. US 8,642,286 B2 entitled, Methods for Identifying Neuripotent Cells by the United States Patent...

Stemedica Announces New Board Member and Chairman of Audit Committee

Stemedica announced today that Richard Mejia, Jr. has joined the Company’s Board of Directors and will be Chairman of the Company’s Audit Committee effective January 31, 2014. Mr. Mejia spent 38 years with Ernst & Young, LLP where he was a partner for 25 years. He...

Stemedica Announces New Chief Financial Officer

Stemedica Cell Technologies, Inc. a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Craig W. Carlson has been appointed the Company’s Chief Financial Officer effective March, 2014. Craig Carlson brings 34 years of...